Search Results - "Perry, Roger R."

Refine Results
  1. 1

    Serum Proteomic Biomarker Discovery Reflective of Stage and Obesity in Breast Cancer Patients by Schaub, Nicholas P., MD, Jones, Kimberly J., BS, Nyalwidhe, Julius O., PhD, Cazares, Lisa H., PhD, Karbassi, Izabela D., PhD, Semmes, O. John, PhD, Feliberti, Eric C., MD, Perry, Roger R., MD, FACS, Drake, Richard R., PhD

    “…Background Currently no standardized blood test exists for breast cancer screening or staging purposes. The goals of this study were to use proteomic mass…”
    Get full text
    Journal Article Conference Proceeding
  2. 2
  3. 3

    Merkel cell carcinoma: high recurrence rate despite aggressive treatment by Soult, Michael C., MD, Feliberti, Eric C., MD, Silverberg, Marc L., MD, Perry, Roger R., MD

    Published in The Journal of surgical research (01-09-2012)
    “…Abstract Background Merkel cell carcinoma (MCC) is a rare aggressive neuroendocrine cancer of the skin whose incidence has been increasing. The objective of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies by Perry, Roger R, Feliberti, Eric C, Hughes, Marybeth S

    Published in Endocrine practice (01-10-2024)
    “…Pancreatic neuroendocrine tumors (PNETs) are uncommon tumors which are increasing in incidence. The management of these tumors continues to evolve. This review…”
    Get more information
    Journal Article
  6. 6

    A Rare Adrenal Incidentaloma That Mimics Adrenocortical Carcinoma by Feliberti, Eric C., Hughes, Marybeth S., Kim, Samuel W., Torabi, Ramyar, Lavingia, Kedar, Perry, Roger R.

    Published in Case reports in surgery (01-01-2018)
    “…Objective. We present a case of an adrenal hemangioma, an uncommon cause of an adrenal mass, and review the clinical presentation, work-up, and management of…”
    Get full text
    Journal Article
  7. 7

    Serum Biomarkers to Differentiate Benign and Malignant Mammographic Lesions by Shin, Susanna, MD, Cazares, Lisa, BS, Schneider, Heather, BS, Mitchell, Shamina, BS, Laronga, Christine, MD, Semmes, O. John, PhD, Perry, Roger R., MD, Drake, Richard R., PhD

    “…Background Mammographic screening has increased detection of earlier-stage breast cancers and has decreased mortality from breast cancer. A Breast…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection by Fournier, Keith, Schiller, Anne, Perry, Roger R, Laronga, Christine

    Published in Annals of surgery (01-06-2004)
    “…To determine if micrometastatic disease in the sentinel lymph node is a predictor of non-sentinel lymph node (non-SLN) involvement in breast cancer. Sentinel…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cutaneous melanoma in Asian-Americans by Shin, Susanna, Palis, Bryan E., Phillips, Jerri Linn, Stewart, Andrew K., Perry, Roger R.

    Published in Journal of surgical oncology (01-02-2009)
    “…Background There is little information available on melanoma in non‐white populations. Our objective was to characterize melanoma in Asian‐Americans (AsA) and…”
    Get full text
    Journal Article
  12. 12

    A Novel Approach Toward Development of a Rapid Blood Test for Breast Cancer by Vlahou, Antonia, Laronga, Christine, Wilson, Lori, Gregory, Betsy, Fournier, Keith, McGaughey, Dean, Perry, Roger R., Wright, George L., Semmes, O. John

    Published in Clinical breast cancer (01-08-2003)
    “…Mammography remains the diagnostic test of choice for breast cancer, but 20% of cancers still go undetected. Many serum biomarkers have been reported for…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Calcitonin-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Multiple Endocrine Neoplasia Type 1 by Ansari, Umer A., Ramirez, Christine L., Feliberti, Eric C., Vinik, Aaron I., Perry, Roger R.

    Published in AACE clinical case reports (01-01-2017)
    “…Objective: To present a patient with multiple endocrine neoplasia type 1 (MEN1) syndrome recently diagnosed with a calcitonin-secreting pancreatic…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer by Hughes, Marybeth, Goffman, Thomas G, Perry, Roger R, Laronga, Christine

    Published in The American journal of surgery (2004)
    “…With increasing sentinel lymph node experience, patient subsets associated with lower success rates are being identified. Obesity may be one such subset. A…”
    Get full text
    Journal Article
  18. 18

    Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells by Perry, R R, Kang, Y, Greaves, B

    Published in Annals of surgical oncology (01-05-1995)
    “…Apoptosis ("programmed cell death") is an active process characterized by prominent nuclear changes and DNA cleavage, which distinguishes it from cellular…”
    Get full text
    Journal Article
  19. 19

    SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers by Laronga, Christine, Becker, Stephen, Watson, Patrice, Gregory, Betsy, Cazares, Lisa, Lynch, Henry, Perry, Roger R, Wright, Jr, George L, Drake, Richard R, Semmes, O John

    Published in Disease markers (01-01-2003)
    “…Surface enhanced laser desorption/ionization (SELDI) time-of-flight mass spectrometry has emerged as a successful tool for serum based detection and…”
    Get full text
    Journal Article
  20. 20

    Role of c-myc in Tamoxifen-Induced Apoptosis in Estrogen-Independent Breast Cancer Cells by Kang, Yuan, Cortina, Robert, Perry, Roger R.

    “…Background The antiestrogen tamoxifen (TAM) is effective in the treatment of estrogen receptor (ER)-positive as well as some ER-negative breast cancers…”
    Get full text
    Journal Article